Rep. Greg Landsman Sells Thermo Fisher Scientific Inc. (NYSE:TMO) Stock

Representative Greg Landsman (D-Ohio) recently sold shares of Thermo Fisher Scientific Inc. NYSE: TMO. In a filing disclosed on April 08th, the Representative disclosed that they had sold between $1,001 and $15,000 in Thermo Fisher Scientific stock on March 27th. The trade occurred in the Representative's "SARAH LANDSMAN TRADITIONAL IRA" account.

Representative Greg Landsman also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of CrowdStrike NASDAQ: CRWD on 3/27/2025.
• Sold $1,001 - $15,000 in shares of Cadence Design Systems NASDAQ: CDNS on 3/27/2025.
• Sold $15,001 - $50,000 in shares of Simon Property Group NYSE: SPG on 3/27/2025.
• Sold $1,001 - $15,000 in shares of L3Harris Technologies NYSE: LHX on 3/27/2025.
• Sold $15,001 - $50,000 in shares of Visa NYSE: V on 3/27/2025.
• Sold $15,001 - $50,000 in shares of Cencora NYSE: COR on 3/27/2025.
• Sold $15,001 - $50,000 in shares of Alphabet NASDAQ: GOOGL on 3/27/2025.
• Sold $1,001 - $15,000 in shares of Ameriprise Financial NYSE: AMP on 3/27/2025.
• Sold $15,001 - $50,000 in shares of Salesforce NYSE: CRM on 3/27/2025.
• Sold $1,001 - $15,000 in shares of Equinix NASDAQ: EQIX on 3/27/2025.

Thermo Fisher Scientific Stock Down 1.9 %

Shares of NYSE:TMO traded down $8.42 on Tuesday, reaching $440.91. The company had a trading volume of 2,545,854 shares, compared to its average volume of 1,707,533. The company has a current ratio of 1.66, a quick ratio of 1.29 and a debt-to-equity ratio of 0.59. The firm has a market capitalization of $166.44 billion, a PE ratio of 26.67, a PEG ratio of 2.99 and a beta of 0.86. Thermo Fisher Scientific Inc. has a 52-week low of $409.85 and a 52-week high of $627.88. The firm's 50 day simple moving average is $505.28 and its 200-day simple moving average is $536.95.

Remove Ads

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last announced its earnings results on Thursday, January 30th. The medical research company reported $6.10 EPS for the quarter, topping analysts' consensus estimates of $5.94 by $0.16. Thermo Fisher Scientific had a net margin of 14.78% and a return on equity of 17.51%. As a group, analysts expect that Thermo Fisher Scientific Inc. will post 23.28 earnings per share for the current fiscal year.

Thermo Fisher Scientific Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Friday, March 14th will be paid a $0.43 dividend. This is an increase from Thermo Fisher Scientific's previous quarterly dividend of $0.39. The ex-dividend date is Friday, March 14th. This represents a $1.72 dividend on an annualized basis and a yield of 0.39%. Thermo Fisher Scientific's payout ratio is 10.41%.

Insider Transactions at Thermo Fisher Scientific

In other news, CEO Marc N. Casper sold 10,000 shares of the business's stock in a transaction dated Tuesday, March 4th. The shares were sold at an average price of $516.67, for a total transaction of $5,166,700.00. Following the completion of the sale, the chief executive officer now owns 115,174 shares of the company's stock, valued at $59,506,950.58. The trade was a 7.99 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Gianluca Pettiti sold 300 shares of the firm's stock in a transaction dated Tuesday, February 4th. The shares were sold at an average price of $585.59, for a total transaction of $175,677.00. Following the completion of the transaction, the executive vice president now directly owns 16,363 shares in the company, valued at $9,582,009.17. This represents a 1.80 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 23,900 shares of company stock valued at $13,106,062 in the last three months. 0.34% of the stock is currently owned by company insiders.

Analyst Ratings Changes

TMO has been the subject of several recent analyst reports. Wells Fargo & Company raised their target price on shares of Thermo Fisher Scientific from $660.00 to $680.00 and gave the company an "overweight" rating in a research note on Friday, January 31st. Scotiabank boosted their target price on Thermo Fisher Scientific from $605.00 to $650.00 and gave the stock a "sector perform" rating in a research note on Monday, February 3rd. Barclays decreased their price target on Thermo Fisher Scientific from $620.00 to $475.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. StockNews.com upgraded shares of Thermo Fisher Scientific from a "hold" rating to a "buy" rating in a report on Tuesday, January 14th. Finally, Sanford C. Bernstein raised shares of Thermo Fisher Scientific from a "market perform" rating to an "outperform" rating and set a $630.00 target price on the stock in a research report on Friday, January 10th. Four analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $647.43.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of TMO. Bernard Wealth Management Corp. acquired a new position in shares of Thermo Fisher Scientific in the 4th quarter valued at $25,000. Legacy Investment Solutions LLC acquired a new position in shares of Thermo Fisher Scientific in the third quarter worth about $26,000. Barrett & Company Inc. purchased a new position in shares of Thermo Fisher Scientific in the 4th quarter valued at about $28,000. FPC Investment Advisory Inc. purchased a new position in Thermo Fisher Scientific during the fourth quarter worth approximately $28,000. Finally, Missouri Trust & Investment Co purchased a new stake in shares of Thermo Fisher Scientific in the fourth quarter valued at approximately $29,000. 89.23% of the stock is owned by institutional investors and hedge funds.

About Representative Landsman

Greg Landsman (Democratic Party) is a member of the U.S. House, representing Ohio's 1st Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027. Landsman (Democratic Party) is running for re-election to the U.S. House to represent Ohio's 1st Congressional District. He declared candidacy for the 2026 election. Greg Landsman was born in Cincinnati, Ohio, and lives in Mt. Washington, Ohio. Landsman earned a B.A. in economics and political science from Ohio University and an M.A. in theological studies, religion, and public policy from Harvard University in 2004. His career experience includes working as the executive director of The Strive Partnership with the KnowledgeWorks Foundation and the director of the Ohio Governor's Office of Faith-Based and Community Initiatives.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.